Two key events, namely adhesion and invasion, are pivotal to the occurrence of metastasis. Importantly, the 37 kDa/67 kDa laminin receptor (LRP/LR) has been implicated in enhancing these two events thus facilitating cancer progression. In the current study, the role of LRP/LR in the adhesion and invasion of liver cancer (HUH-7) and leukaemia (K562) cells was investigated. Flow cytometry revealed that the HUH-7 cells displayed significantly higher cell surface LRP/LR levels compared to the poorly-invasive breast cancer (MCF-7) control cells, whilst the K562 cells displayed significantly lower cell surface LRP/LR levels in comparison to the MCF-7 control cells. However, Western blotting and densitometric analysis revealed that all three tumorigenic cell lines did not differ significantly with regards to total LRP/LR levels. Furthermore, treatment of liver cancer cells with anti-LRP/LR specific antibody IgG1-iS18 (0.2 mg/ml) significantly reduced the adhesive potential of cells to laminin-1 and the invasive potential of cells through the ECM-like Matrigel, whilst leukaemia cells showed no significant differences in both instances. Additionally, Pearson's correlation coefficients suggested direct proportionality between cell surface LRP/LR levels and the adhesive and invasive potential of liver cancer and leukaemia cells. These findings suggest the potential use of anti-LRP/LR specific antibody IgG1-iS18 as an alternative therapeutic tool for metastatic liver cancer through impediment of the LRP/LR- laminin-1 interaction.
References
[1]
Jemal A, Bray F (2011) Center MM, Ferlay J, Ward E, et al (2011) Global cancer statistics. CA Cancer J Clin 61: 69–90. doi: 10.3322/caac.20107
[2]
Frantz C, Stewart KM, Weaver VM (2010) The extracellular matrix at a glance. J Cell Sci 123: 4195–4200. doi: 10.1242/jcs.023820
[3]
Mbazima V, Da Costa Dias B, Omar A, Jovanovic K, Weiss SF (2010) Interactions between PrP(c) and other ligands with the 37-kDa/67-kDa laminin receptor. Front Biosci 15: 1150–1163. doi: 10.2741/3667
[4]
Omar A, Reusch U, Knackmuss S, Little M, Weiss SF (2012) Anti-LRP/LR-specific antibody IgG1-iS18 significantly reduces adhesion and invasion of metastatic lung, cervix, colon and prostate cancer cells. J Mol Biol 419: 102–109. doi: 10.1016/j.jmb.2012.02.035
[5]
Vana K, Zuber C, Pflanz H, Kolodziejczak D, Zemora G, et al. (2009) LRP/LR as an alternative promising target in therapy of prion diseases, Alzheimer's disease and cancer. Infect Disord Drug Targets 9: 69–80. doi: 10.2174/1871526510909010069
[6]
Buto S, Tagliabue E, Ardini E, Magnifico A, Ghirelli C, et al. (1998) Formation of the 67-kDa laminin receptor by acylation of the precursor. J Cell Biochem 69: 244–251. doi: 10.1002/(sici)1097-4644(19980601)69:3<244::aid-jcb2>3.0.co;2-r
[7]
Salama RH, Muramatsu H, Zou K, Inui T, Kimura T, et al. (2001) Midkine binds to 37-kDa laminin binding protein precursor, leading to nuclear transport of the complex. Exp Cell Res 270: 13–20. doi: 10.1006/excr.2001.5341
[8]
Sato M, Kinoshita K, Kaneda Y, Saeki Y, Iwamatsu A, et al. (1996) Analysis of nuclear localization of laminin binding protein precursor p40 (LBP/p40). Biochem Biophys Res Commun 229: 896–901. doi: 10.1006/bbrc.1996.1899
[9]
Vande Broek I, Vanderkerken K, De Greef C, Asosingh K, Straetmans N, et al. (2001) Laminin-1-induced migration of multiple myeloma cells involves the high-affinity 67 kD laminin receptor. Br J Cancer 85: 1387–1395.
[10]
Canfield SM, Khakoo AY (1999) The nonintegrin laminin binding protein (p67 LBP) is expressed on a subset of activated human T lymphocytes and, together with the integrin very late activation antigen-6, mediates avid cellular adherence to laminin. J Immunol 163: 3430–3440.
[11]
Malinda KM, Kleinman HK (1996) The laminins. Int J Biochem Cell Biol 28: 957–959. doi: 10.1016/1357-2725(96)00042-8
[12]
Engvall E, Wewer UM (1996) Domains of laminin. J Cell Biochem 61: 493–501. doi: 10.1002/(sici)1097-4644(19960616)61:4<493::aid-jcb2>3.3.co;2-h
[13]
Giancotti FG (1996) Signal transduction by the alpha 6 beta 4 integrin: charting the path between laminin binding and nuclear events. J Cell Sci 109 (Pt 6): 1165–1172.
[14]
Aznavoorian S, Stracke ML, Krutzsch H, Schiffmann E, Liotta LA (1990) Signal transduction for chemotaxis and haptotaxis by matrix molecules in tumor cells. J Cell Biol 110: 1427–1438. doi: 10.1083/jcb.110.4.1427
[15]
Weeks BS, DiSalvo J, Kleinman HK (1990) Laminin-mediated process formation in neuronal cells involves protein dephosphorylation. J Neurosci Res 27: 418–426. doi: 10.1002/jnr.490270321
[16]
Khusal R, Da Costa Dias B, Moodley K, Penny C, Reusch U, et al. (2013) In Vitro Inhibition of Angiogenesis by Antibodies Directed against the 37 kDa/67 kDa Laminin Receptor. PLOS ONE 8: e58888. doi: 10.1371/journal.pone.0058888
[17]
Givant-Horwitz V, Davidson B, Reich R (2004) Laminin-induced signaling in tumor cells: the role of the M(r) 67,000 laminin receptor. Cancer Res 64: 3572–3579. doi: 10.1158/0008-5472.can-03-3424
[18]
Zuber C, Knackmuss S, Zemora G, Reusch U, Vlasova E, et al. (2008) Invasion of tumorigenic HT1080 cells is impeded by blocking or downregulating the 37-kDa/67-kDa laminin receptor. J Mol Biol 378: 530–539. doi: 10.1016/j.jmb.2008.02.004
[19]
Fidler IJ, Radinsky R (1990) Genetic control of cancer metastasis. J Natl Cancer Inst 82: 166–168. doi: 10.1093/jnci/82.3.166
[20]
Khumalo T, Reusch U, Knackmuss S, Little M, Veale RB, et al. (2013) Adhesion and Invasion of Breast and Oesophageal Cancer Cells Are Impeded by Anti-LRP/LR-Specific Antibody IgG1-iS18. PLOS ONE 8: e66297. doi: 10.1371/journal.pone.0066297
[21]
Ardini E, Sporchia B, Pollegioni L, Modugno M, Ghirelli C, et al. (2002) Identification of a novel function for 67-kDa laminin receptor: increase in laminin degradation rate and release of motility fragments. Cancer Res 62: 1321–1325.
[22]
Stetler-Stevenson M, Mansoor A, Lim M, Fukushima P, Kehrl J, et al. (1997) Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in reactive and neoplastic lymphoid cells. Blood 89: 1708–1715.
[23]
Fulop T, Larbi A (2002) Putative role of 67 kDa elastin-laminin receptor in tumor invasion. Semin Cancer Biol 12: 219–229. doi: 10.1016/s1044-579x(02)00025-1
[24]
Zhou L, Xie M, Zhou JQ, Tao L (2006) 67-kDa laminin receptor in human laryngeal squamous cell carcinoma. Laryngoscope 116: 28–32. doi: 10.1097/01.mlg.0000184505.05662.b9
